Ideaya Enterprise Value Over E B I T D A from 2010 to 2024
| IDYA Stock | USD 26.79 0.19 0.71% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter (14.51) | Current Value (15.24) | Quarterly Volatility 3.50608897 |
Check Ideaya Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ideaya Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 22.5 M, Interest Income of 22.5 M or Discontinued Operations of 0.0, as well as many indicators such as Price To Sales Ratio of 91.89, Dividend Yield of 0.0 or PTB Ratio of 3.46. Ideaya financial statements analysis is a perfect complement when working with Ideaya Biosciences Valuation or Volatility modules.
Ideaya | Enterprise Value Over E B I T D A |
Latest Ideaya Biosciences' Enterprise Value Over E B I T D A Growth Pattern
Below is the plot of the Enterprise Value Over E B I T D A of Ideaya Biosciences over the last few years. It is Ideaya Biosciences' Enterprise Value Over EBITDA historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Ideaya Biosciences' overall financial position and show how it may be relating to other accounts over time.
| Enterprise Value Over E B I T D A | 10 Years Trend |
|
Enterprise Value Over E B I T D A |
| Timeline |
Ideaya Enterprise Value Over E B I T D A Regression Statistics
| Arithmetic Mean | (10.72) | |
| Coefficient Of Variation | (32.71) | |
| Mean Deviation | 2.28 | |
| Median | (11.15) | |
| Standard Deviation | 3.51 | |
| Sample Variance | 12.29 | |
| Range | 12.4856 | |
| R-Value | (0.16) | |
| Mean Square Error | 12.91 | |
| R-Squared | 0.02 | |
| Significance | 0.58 | |
| Slope | (0.12) | |
| Total Sum of Squares | 172.10 |
Ideaya Enterprise Value Over E B I T D A History
About Ideaya Biosciences Financial Statements
Ideaya Biosciences stakeholders use historical fundamental indicators, such as Ideaya Biosciences' Enterprise Value Over E B I T D A, to determine how well the company is positioned to perform in the future. Although Ideaya Biosciences investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ideaya Biosciences' assets and liabilities are reflected in the revenues and expenses on Ideaya Biosciences' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ideaya Biosciences. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Enterprise Value Over EBITDA | (14.51) | (15.24) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Ideaya Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ideaya Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ideaya Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ideaya Biosciences Stock:Check out the analysis of Ideaya Biosciences Correlation against competitors. For information on how to trade Ideaya Stock refer to our How to Trade Ideaya Stock guide.You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ideaya Biosciences. If investors know Ideaya will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ideaya Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.33) | Revenue Per Share 0.051 | Quarterly Revenue Growth (0.03) | Return On Assets (0.16) | Return On Equity (0.21) |
The market value of Ideaya Biosciences is measured differently than its book value, which is the value of Ideaya that is recorded on the company's balance sheet. Investors also form their own opinion of Ideaya Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Ideaya Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ideaya Biosciences' market value can be influenced by many factors that don't directly affect Ideaya Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ideaya Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ideaya Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ideaya Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.